TiGenix NV (TIG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

TiGenix NV (TIG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

TiGenix NV (TIG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
TiGenix NV (TIG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 23, 2016
40 pages — Published Sep 23, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

TiGenix NV (TiGenix) is a biopharmaceutical company that develops and commercializes novel therapeutics. The company provides adult stem cell programs based on proprietary validated platforms of allogeneic expanded stem cells. Its product portfolio includes AlloCSC-01, ChondroCelect, AlloCSC-02, Cx611 and Cx601. TiGenixs chondro celect is a cell-based medicinal product for use in autologous chondrocyte, and then re-implanted at the site of the defect and is used for cartilage repair in the knee. The company uses its platform which has been developed using expanded stem cells extracted from adipose tissue, and are sourced from and applied to consenting patients.

TiGenix NV (TIG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- De

  
Source:
Document ID
GDPH22481D
Country
Industry
Ticker
TIG=BE
Company
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
TiGenix NV, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
TiGenix NV, Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
TiGenix NV, Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
TiGenix NV, Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
TiGenix NV, Medical Devices Deals, 2010 to YTD 201691
TiGenix NV, Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016101
TiGenix NV, Pharmaceuticals &Healthcare, Deal Details1126
  Partnerships111
    TiGenix Forms Partnership with TFS International111
    TiGenix To Enter Into Co-Marketing Agreement For Cx601121
    TiGenix Enters Into Joint Venture With Katholieke Universiteit Leuven, Ghent University And Therosteon132
  Merger151
    TiGenix Completes Merger With Cellerix152
  Licensing Agreements171
    Takeda Pharma Enters into Licensing Agreement with TiGenix for Cx601172
    TiGenix Enters Licensing Agreement With Sobi For ChondroCelect192
  Equity Offering211
    TiGenix Raises USD26 Million in Private Placement of Shares212
    TiGenix Files Registration Statement for IPO of ADS for up to USD57.5 Million232
    TiGenix Raises USD9.2 Million in Private Placement of Shares252
    TiGenix Completes Private Placement Of Shares For US$16.2 Million272
    TiGenix Completes Private Placement Of Shares For US$8.5 Million291
    TiGenix Completes Private Placement Of Shares For US$9 Million301
  Debt Offering311
    TiGenix Raises USD28.3 Million in Private Placement of 9% Bonds Due 2018312
    TiGenix Announces Private Placement Of Debt Securities For US$13.7 Million331
  Acquisition341
    TiGenix Acquires Coretherapix from Genetrix342
    PharmaCell Completes Acquisition of TiGenix, Operator of Cell Therapy Production Facility in Netherlands for USD7.8 Million361
TiGenix NV - Key Competitors371
Key Employees381
Locations And Subsidiaries391
  Head Office391
  Other Locations &Subsidiaries391
Appendix401
  Methodology401
  About GlobalData401
  Contact Us401
  Disclaimer401

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "TiGenix NV (TIG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 23, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/TiGenix-NV-TIG-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-13966>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). TiGenix NV (TIG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 23, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/TiGenix-NV-TIG-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-13966>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research